About Penumbra, Inc. 
Penumbra, Inc.
Pharmaceuticals & Biotechnology
Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.
Company Coordinates 
Company Details
1 Penumbra , ALAMEDA CA : 94502-7676
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 117 Schemes (61.78%)
Foreign Institutions
Held by 183 Foreign Institutions (11.11%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Adam Elsesser
Chairman of the Board, Chief Executive Officer
Dr. Arani Bose
Chief Innovator, Director
Mr. Harpreet Grewal
Independent Director
Mr. Don Kassing
Presiding Independent Director
Ms. Janet Leeds
Independent Director
Ms. Bridget O'Rourke
Independent Director
Ms. Surbhi Sarna
Independent Director
Revenue and Profits:
Net Sales:
339 Million
(Quarterly Results - Jun 2025)
Net Profit:
45 Million
Pharmaceuticals & Biotechnology
USD 11,138 Million (Small Cap)
84.00
NA
0.00%
-0.32
11.41%
8.61






